These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15278297)

  • 1. Immunofluorescent analysis with the anti-PML monoclonal antibody PG-M3 for rapid and accurate genetic diagnosis of acute promyelocytic leukemia.
    Gomis F; Sanz J; Sempere A; Plumé G; Senent ML; Pérez ML; Cervera J; Moscardó F; Bolufer P; Barragán E; Martín G; Sanz MA
    Ann Hematol; 2004 Nov; 83(11):687-90. PubMed ID: 15278297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML).
    Falini B; Flenghi L; Fagioli M; Lo Coco F; Cordone I; Diverio D; Pasqualucci L; Biondi A; Riganelli D; Orleth A; Liso A; Martelli MF; Pelicci PG; Pileri S
    Blood; 1997 Nov; 90(10):4046-53. PubMed ID: 9354674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid diagnosis of acute promyelocytic leukemia by analyzing the immunocytochemical pattern of the PML protein with the monoclonal antibody PG-M3.
    Villamor N; Costa D; Aymerich M; Esteve J; Carrió A; Rozman M; Aguilar JL; Falini B; Montserrat E; Campo E; Colomer D
    Am J Clin Pathol; 2000 Nov; 114(5):786-92. PubMed ID: 11068554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunostaining for rapid diagnosis of acute promyelocytic leukemia with the tetramethylrhodamine-5-isothiocyanate-conjugated anti-promyelocytic leukemia monoclonal antibody PG-M3.
    Alayed KM; Medeiros LJ; Phan D; Ojiaku C; Patel J; Yap JP; McCord Y; Woods JS; Konoplev S; Bueso-Ramos CE; Reyes SR
    Arch Pathol Lab Med; 2013 Nov; 137(11):1669-73. PubMed ID: 24168508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunofluorescent assay for acute promyelocytic leukemia cells.
    Samoszuk MK; Tynan W; Sallash G; Nasr S; Monczak Y; Miller WH
    Am J Clin Pathol; 1998 Feb; 109(2):205-10. PubMed ID: 9583893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes.
    Paietta E; Goloubeva O; Neuberg D; Bennett JM; Gallagher R; Racevskis J; Dewald G; Wiernik PH; Tallman MS;
    Cytometry B Clin Cytom; 2004 May; 59(1):1-9. PubMed ID: 15108165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and reliable confirmation of acute promyelocytic leukemia by immunofluorescence staining with an antipromyelocytic leukemia antibody: the M. D. Anderson Cancer Center experience of 349 patients.
    Dimov ND; Medeiros LJ; Kantarjian HM; Cortes JE; Chang KS; Bueso-Ramos CE; Ravandi F
    Cancer; 2010 Jan; 116(2):369-76. PubMed ID: 19950129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
    Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
    Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a new monoclonal antibody (PG-M3) directed against the aminoterminal portion of the PML gene product: immunocytochemical evidence for high expression of PML proteins on activated macrophages, endothelial cells, and epithelia.
    Flenghi L; Fagioli M; Tomassoni L; Pileri S; Gambacorta M; Pacini R; Grignani F; Casini T; Ferrucci PF; Martelli MF
    Blood; 1995 Apr; 85(7):1871-80. PubMed ID: 7535592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.
    Allford S; Grimwade D; Langabeer S; Duprez E; Saurin A; Chatters S; Walker H; Roberts P; Rogers J; Bain B; Patterson K; McKernan A; Freemont P; Solomon E; Burnett A; Goldstone A; Linch D
    Br J Haematol; 1999 Apr; 105(1):198-207. PubMed ID: 10233384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Improved RT-PCR for detection of PML/RARalpha fusion gene in rapid diagnosis of acute promyelocytic leukemia].
    Liu ZL; Luo JM; Wang FX; Zhang XJ; Du XY; Yao L; Dong ZR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):587-90. PubMed ID: 14706140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid diagnosis of acute promyelocytic leukemia by immunohistochemical localization of PML/RAR-alpha protein.
    Dyck JA; Warrell RP; Evans RM; Miller WH
    Blood; 1995 Aug; 86(3):862-7. PubMed ID: 7620182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid diagnosis of acute promyelocytic leukemia (PML): applicability of flow cytometry and PML protein immunofluorescence.
    Cullen MJ; Richards SJ; O'Connor SJ; Dickinson H; Sharpe C; Swirsky DM; Owen R
    Cancer Genet Cytogenet; 2004 Jan; 148(2):176-7. PubMed ID: 14734236
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of PG-M3 antibody in the diagnosis of acute promyelocytic leukaemia.
    Gupta SK; Sazawal S; Mahapatra M; Saxena R
    Eur J Clin Invest; 2010 Oct; 40(10):960-2. PubMed ID: 20701624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Change of PML/PML-RARalpha protein during treatment with tetraarsenic tetrasulfide (As4S4) in patients with acute promyelocytic leukemia].
    Wang JZ; Liu YR; Qin YZ; Jiang H; Wang FR; Bao L; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):464-8. PubMed ID: 14575537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid diagnostic approach to PML-RARalpha-positive acute promyelocytic leukemia.
    Schoch C; Schnittger S; Kern W; Lengfelder E; Löffler H; Hiddemann W; Haferlach T
    Hematol J; 2002; 3(5):259-63. PubMed ID: 12391544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute promyelocytic leukemia: from clinic to molecular biology.
    Chen SJ; Wang ZY; Chen Z
    Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse transcription-polymerase chain reaction for PML-RAR alpha fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection.
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Leukemia; 1993 Apr; 7(4):544-8. PubMed ID: 8385249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse.
    Grimwade D; Howe K; Langabeer S; Burnett A; Goldstone A; Solomon E
    Leukemia; 1996 Jan; 10(1):61-6. PubMed ID: 8558940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute promyelocytic leukemia M3: cytomorphologic, immunophenotypic, cytogenetic, and molecular variants.
    Sucić M; Zadro R; Burazer B; Labar B; Nemet D; Mrsić M; Aurer I; Mrsić S; Hitrec V; Boban D; Marković-Glamocak M; Batinić D; Uzarević B; Stavljenić-Rukavina A
    J Hematother Stem Cell Res; 2002 Dec; 11(6):941-50. PubMed ID: 12590709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.